Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

<div><p>Immune checkpoint inhibitors provide considerable therapeutic benefit in a range of solid cancers as well as in a subgroup of hematological malignancies. Response rates are however suboptimal, and despite considerable efforts, predicting response to immune checkpoint inhibitors a...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Allan Relecom (14153295) (author)
مؤلفون آخرون: Maysaloun Merhi (4246147) (author), Varghese Inchakalody (15263530) (author), Shahab Uddin (154400) (author), Darawan Rinchai (742366) (author), Davide Bedognetti (2632474) (author), Said Dermime (79420) (author)
منشور في: 2021
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!